Skip to main content
Equibles

BENJAMIN EDWARDS INC

Position in ANIX — Anixa Biosciences Inc

CIK 1451623 Clayton, MO
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$31,360
+$2,464 QoQ
Shares Held
11,200
0.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 62 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BENJAMIN EDWARDS INC holds $17,504,041 across 16 Biotechnology names. ANIX ranks #16 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,025 $5,476,447
2 CRSP
CRISPR Therapeutics AG
 54,488 $2,971,774
3 TWST
Twist Bioscience Corp
 21,822 $2,245,047
4 REGN
Regeneron Pharmaceuticals, Inc.
 2,613 $1,629,310
5 NTLA
Intellia Therapeutics, Inc.
 80,881 $1,368,506
6 BEAM
Beam Therapeutics Inc.
 31,009 $1,064,228
7 ARWR
Arrowhead Pharmaceuticals, Inc.
 8,841 $720,629
8 RXRX
Recursion Pharmaceuticals, Inc.
 168,540 $618,540

All Filings in ANIX

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,360 11,200
2026-03-31 $28,896 11,200
2025-12-31 $34,944 11,200
2025-09-30 $36,960 11,200
2025-06-30 $36,960 11,200